NeuroThera® Efficacy and Safety Trial - 3 (NEST-3): A double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24h of stroke onset

International Journal of Stroke

Volumn 9, Issue 7, 2014, Pages 950-955

  Zivin, J A ^a   Sehra, R ^b   Shoshoo, A ^b   Albers, G W ^c   Bornstein, N M ^d   Dahlof, B ^e   Kasner, S E ^f   Howard, G ^g   Shuaib, A ^h   Streeter, J ⁱ   Richieri, S P ^b   Hacke, W ^j   Elfont, Rob ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PhotoThera Inc   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

ⁱ Banyan Biomarkers   (United States)

^j UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Acute ischemic stroke; Clinical trial; Stroke outcomes; Transcranial laser therapy

Indexed keywords

ADULT; AGED; AMERICAN STROKE ASSOCIATION; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EUROPEAN STROKE ORGANIZATION GUIDELINES; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SHAM PROCEDURE; TRANSCRANIAL LASER THERAPY; ADVERSE EFFECTS; CLINICAL TRIAL; DEVICES; FOLLOW UP; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; STROKE; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MIDDLE AGED; PATIENT SELECTION; STROKE; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84907877003     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00896.x     Document Type: Article

References (27)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-1587.
2. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
3. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40:2945-2948.
4. Ringleb PA, Bousser M, Ford G etal. ESO guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Available at http://www.eso-stroke.org/pdf/ESO%20Guidelines_update_Jan_2009.pdf
5. Adeoye O, Hornung R, Khatri P, Recombinant KD. Tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011; 42:1952-1955.
6. Lloyd-Jones D, Adams RJ, Brown TM etal. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010; 121:e46-e215.
7. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009; 40:111-114.
8. Priestley J. Experiments and Observations on Different Kinds of Air. London W. Bowyer and J. Nichols, 1774
9. Priestley J. Experiments and observations on different kinds of air. Vol. 2. London: printed for J. Johnson, 1775
10. Priestley J. Experiments and observations on different kinds of air. London: printed for J. Johnson, 1777.
11. Warburg O. The chemical constitution of respiration ferment. Science 1928; 68:437-443.
12. Karu T. Ten Lectures on Basic Science of Laser Phototherapy. Grangesberg, Prima Books, 2007.
13. Carnevalli C, Soares C, Zangaro R, Pinheiro A, Silva N. Laser light prevents apoptosis on Cho K1 cell line. J Clin Laser Med Surg 2003; 21:193-196.
14. Karu T, Pyatibrat LV, Afanasyev NI. Cellular effects of low power laser therapy can be mediated by nitric oxide. Lasers Surg Med 2005; 36:307-314.
15. Lapchak P, Wei J, Zivin J. Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 2004; 35:1985-1988.
16. Oron A, Oron U, Chen J. Low level laser therapy applied transcranially to rats following induction of stroke significantly reduces long-term neurological deficit. Stroke 2006; 37:2620-2624.
17. DeTaboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J. Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med 2006; 38:70-73.
18. Lampl Y, Zivin JA, Fisher M etal. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 2007; 38:1843-1849.
19. Zivin JA, Albers GW, Bornstein N etal. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke 2009; 40:1359-1364.
20. Sacco RL, Adams R, Albers G etal. Guideline for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37:577-617.
21. Adams HP, del Zoppo G, Alberts MJ etal. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Artherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655-1711.
22. Duncan PW, Zorowitz R, Bates B etal. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36:e100-e143.
23. Lyden P, Raman R, Liu L etal. NIHSS training and certification using a new digital video disk is reliable. Stroke 2005; 36:2446-2449.
24. Quinn TJ, Lees KR, Hardemark H-G, Dawson J, Walters MR. Initial experience of a digital training resource for modified Rankin Scale assessment in clinical trials. Stroke 2007; 38:2257-2261.
25. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
26. Pennello G, Thompson L. Experience with reviewing Bayesian medical device trials. J Biopharm Stat 2008; 18:81-115.
27. Guidance for Industry and FDA Staff. Guidance for the use of Bayesian statistics in medical device clinical trials. 2010. Available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071121.pdf